FDA Inspection 978492 — Jazz Pharmaceuticals, Inc
The FDA completed an inspection of Jazz Pharmaceuticals, Inc on July 20, 2016 in Palo Alto, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 20, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Palo Alto, CA (United States)